stroke • stroke prevention • acute management • clinical research
My research focuses on clinical studies in the areas of stroke prevention and acute management. This includes interventional (surgery), medical (drugs) or lifestyle approaches. We are actively involved in different clinical studies which involve the detection of specific causes of stroke (detection of cardiac problem such as atrial fibrillation), control of vascular risk factors (high blood pressure, diabetes and high cholesterol), use of blood thinners and changes in lifestyle habits (smoking and other). Our studies are often done in collaboration with other centers either across Canada or at the international level. We are also presently involved in the establishment of a program which supports best practices in stroke care at the MUHC and will monitor different clinical indicators of quality of care in stroke management through a dedicated database.
Mittmann N, Seung SJ, Hill MD, Phillips SJ, Hachinski V, Côté R, Buck BH, Mackey A, Gladstone DJ, Howse DC, Shuaib A, Sharma M. Impact of disability status on ischemic stroke costs in Canada in the first year. Can J Neurol Sci. 2012;39:793-800.
Saposnik G, Kapral MK, Côté R, Rochon PA, Wang J, Raptis S, Mamdani M, Black SE. Is pre-existing dementia an independent predictor of outcome after stroke? A propensity score-matched analysis. J Neurol 2012;259:2366-2375.
Krueger H, Lindsay P, Côté R, Kapral MK, Kaczorowski J, Hill MD. Cost avoidance associated with optimal stroke care in Canada. Stroke 2012;43:2198-2206.
Perreault S, Yu AYX, Côté R, Dragomir A, White-Guay B, Dumas S. Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes. Neurology 2012;79:2037-2043.
Saposnik G,Cote R,Mamdami M,Raptis S et al. JURaSSiC:Accuracy of Physician vs Risk Score Prediction of Ischemic Stroke Outcomes.Neurology 2013;81:448-455.